Gene · 3455
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Non-Coding RNAs Can Govern the Antiviral Immune Response Through Interferon-Mediated Mechanisms in Respiratory Tract. | Viruses | 2026 | 41754574 | PubTator, text mining | PubMed |
| Beyond Viral Restriction: The Metabolic Dimensions of Interferon-Stimulated Genes in Antiviral Immunity. | Viruses | 2026 | 41754503 | PubTator, text mining | PubMed |
| Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses. | Pathogens | 2026 | 41754484 | PubTator, text mining | PubMed |
| Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon-mediated fibrosis. | J Hum Immun | 2026 | 41743834 | PubTator, text mining | PubMed |
| Targeting immune checkpoint therapy: The role of manganese in tumor immunotherapy. | Cancer Pathog Ther | 2026 | 41732211 | PubTator, text mining | PubMed |
| Editorial: Community series in SARS-CoV-2 variants, B lymphocytes, and autoreactivity, volume II. | Front Immunol | 2026 | 41727483 | PubTator, text mining | PubMed |
| Type I Interferons Induce CD8+ T Cell Chemotaxis Through Regulating Melanocyte but Not Keratinocyte CXCL9/10/11 Secretion in the Initiation of Vitiligo. | FASEB J | 2026 | 41689465 | PubTator, text mining | PubMed |
| Dissection of innate-immune-ligand- and interferon-protein-mediated transcriptional responses in human THP1 cell states. | Commun Biol | 2026 | 41680413 | PubTator, text mining | PubMed |
| PI3Kγ Pathway Contributes to Neuroinflammation and Neuronal Death Induced by Zika Virus Infection. | Immunology | 2026 | 41652994 | PubTator, text mining | PubMed |
| Self-aggregating Lactiplantibacillus plantarum enhances type-I interferon responses via the cytosolic sensors NOD2 and cGAS. | Gut Microbes | 2026 | 41605865 | PubTator, text mining | PubMed |
| Human autoantibodies against type I interferons in severe viral disease. | Curr Opin Virol | 2026 | 41605119 | PubTator, text mining | PubMed |
| Mapping targetable sites on the human surfaceome for the design of novel binders. | Proc Natl Acad Sci U S A | 2026 | 41604262 | PubTator, text mining | PubMed |
| Explainable AI multiomics analysis reveals shared and divergent host responses in COVID-19 and influenza. | NPJ Digit Med | 2026 | 41593342 | PubTator, text mining | PubMed |
| COVID-19 Outcomes and Risk Factors for Hospitalization in Adult Patients With Primary Immunodeficiency. | Allergy Asthma Immunol Res | 2026 | 41592542 | PubTator, text mining | PubMed |
| A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections. | PLoS Pathog | 2026 | 41592114 | PubTator, text mining | PubMed |
| Genetic contribution to severe COVID-19 in adults under 60 years without major comorbidities in the German National Pandemic Cohort Network (NAPKON). | Hum Genomics | 2026 | 41578410 | PubTator, text mining | PubMed |
| Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome. | Nat Commun | 2026 | 41571684 | PubTator, text mining | PubMed |
| Animal models illuminate dengue immunopathogenesis to guide vaccine and therapeutic developments. | J Virol Methods | 2026 | 41548813 | PubTator, text mining | PubMed |
| The splice of life: how alternative splicing shapes regulatory and phenotypic evolution. | EMBO J | 2026 | 41545761 | PubTator, text mining | PubMed |
| Causal splicing variants revealed by deep-learning integration of single-cell sQTL mapping under influenza infection. | Res Sq | 2026 | 41542048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3455/papers?page=3